Eterna Therapeutics Inc. has entered into a Securities Purchase Agreement where it raised $8,715,000 via the private placement of Senior Convertible Promissory Notes and warrants which are convertible into the company's common stock. The proceeds from the private placement will be used for general working capital purposes.